HF3701
Long-term care, life, and disability insurers prohibited from using genetic information for certain purposes.
Legislative Session 94 (2025-2026)
Related bill: SF3989
AI Generated Summary
Purpose
This bill would limit how insurers that sell long-term care, life, or disability insurance can use genetic information. It aims to prevent genetic data from being used to deny coverage, raise premiums, or require genetic testing as a condition for getting or renewing a policy. It also updates definitions related to genetics and insurance and removes some older provisions.
Main Provisions
- Prohibition on discriminatory use of genetic information
- Insurers cannot deny, cancel, limit, or set higher premiums for an individual or their family members based solely on genetic information.
- Prohibition on pressuring genetic testing
- Insurers cannot require or coercively encourage someone to undergo genetic testing (including full genomic sequencing) as a condition for coverage, renewal, or pricing.
- Consent-based use of existing health information
- Insurers may access or use existing health information for underwriting only if the individual provides prior written consent.
- The consent must be presented separately from any other authorization to release medical records.
- Protection for individuals without genetic testing consent
- An insurer cannot deny or refuse to issue or renew a policy because the individual did not provide consent for genetic information.
- A medical diagnosis in an individual’s records that results from a genetic test cannot be used to deny or cancel coverage if it concerns the person being evaluated.
- Definitions and scope
- Defines genetic information and genetic test (presymptomatic tests for genes or chromosomes, including carrier status, related to disease risk; excludes cholesterol tests from being considered genetic tests).
- Clarifies terms such as health plan, health plan company, insurer, and individual.
- Changes to law
- Amends Minnesota Statutes 2024 section 72A.139 subdivision 2 and repeals subdivisions 4–7 of 72A.139.
- Coverage scope
- Applies to insurers offering long-term care insurance, life insurance, and disability insurance.
Key Definitions (for clarity)
- Genetic information: information derived from a genetic test.
- Genetic test: presymptomatic testing for genes, gene products, or chromosomes to determine presence/absence of disease-related abnormalities or to identify carrier status; includes tests that show increased risk, but excludes non-genetic tests like a cholesterol test.
- Underwriting, premiums, coverage renewal, pricing: standard insurance industry terms affected by how information is used in deciding eligibility and costs.
Significant Changes to Existing Law
- Establishes a broad prohibition on using genetic information for underwriting decisions or price setting.
- Prohibits coercion or conditioning of coverage on genetic testing.
- Requires separate, explicit consent to use existing health information for underwriting.
- Tightens protections for individuals by preventing denial or non-renewal based on lack of consent or genetic-test-derived diagnoses in medical records.
- Replaces or supersedes specific older provisions by repealing subdivisions 4–7 of the existing section.
Practical Implications
- Individuals seeking long-term care, life, or disability insurance should not have their coverage unfairly denied or priced higher simply due to genetic test results.
- Insurers cannot force people to take genetic tests as a condition of obtaining or renewing coverage.
- If a person consents to the use of existing health information (including genetics) for underwriting, it must be a separate consent, clearly separated from other authorizations.
- Medical diagnoses connected to genetics in a health record cannot automatically block coverage if the person did not consent to use of that genetic information.
Relevant Terms genetic information; genetic test; presymptomatic test; carrier status; health plan; health plan company; insurer; individual; underwriting; premiums; coverage renewal; pricing; long-term care insurance; life insurance; disability insurance; consent; separate consent; medical records; genetic data use prohibition; denial of coverage based on genetics.
Actions
| Date | Chamber | Where | Type | Name | Committee Name |
|---|---|---|---|---|---|
| February 25, 2026 | House | Action | Introduction and first reading, referred to | Commerce Finance and Policy | |
| February 26, 2026 | House | Action | Author added | ||
| March 12, 2026 | House | Action | Author added | ||
| April 07, 2026 | House | Action | Author added | ||
| Showing the 5 most recent stages. This bill has 4 stages in total. Log in to view all stages | |||||
Citations
You must be logged in to view citations.
Progress through the legislative process
Sponsors
You must be logged in to view sponsors.